Alternatives to Statins for Patients with Suspected Myopathy
Diagnosis and Confirmation of Statin-Associated Myopathy
- The American Heart Association recommends obtaining creatine kinase (CK) measurements when patients report muscle soreness, tenderness, or pain to confirm myopathy, and to rule out common causes such as exercise, strenuous work, or hypothyroidism (check TSH) before attributing symptoms to statin therapy 2
- The American College of Cardiology suggests evaluating for risk factors that predispose to statin myopathy: advanced age (especially >80 years), female gender, small body frame, frailty, multisystem disease (especially chronic renal insufficiency), multiple medications, and perioperative periods 3
Management Algorithm Based on Symptom Severity
- For patients with mild to moderate symptoms, the American College of Cardiology recommends trying a different statin with lower myopathy risk, such as pravastatin or fluvastatin, due to fewer drug interactions 4
- The American Heart Association suggests considering once-weekly rosuvastatin (long half-life makes it suitable for less frequent dosing) as an alternative dosing strategy to reduce myopathy risk 1
Important Considerations and Caveats
- The American College of Cardiology states that myopathy risk is dose-dependent, and recommends using the lowest effective dose to achieve cholesterol goals 3
- The American Heart Association warns that drug interactions significantly increase myopathy risk, and advises avoiding combining statins with cytochrome P-450 inhibitors, gemfibrozil, cyclosporine, and certain macrolide antibiotics 4
- The American College of Cardiology notes that statin-fibrate combinations have higher myopathy risk than statin-niacin combinations 2
- The American Heart Association suggests that weekly dosing provides less LDL-C reduction than daily dosing, but some reduction is better than complete discontinuation in high-risk patients 1